Interactive Educational Website for Women With Ovarian Cancer & Caregivers
| Status: | Completed |
|---|---|
| Conditions: | Ovarian Cancer, Cancer, Cancer, Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | August 2012 |
| End Date: | December 2014 |
Making End of Life Decision in Ovarian Cancer: When to Enter Hospice? A Prototype Interactive Computer Program for Patients and Providers
Ovarian cancer accounts for more deaths than any other gynecologic malignancy. The majority
of patients are diagnosed with Stage III-IV disease. Nearly 80% of these patients will recur
resulting in 5-year survival rates of 14-32%. Although enrollment is increasing in hospice,
hospice programs have been challenged to reach eligible patients. Several factors limit the
number of people who enroll in hospice and the length of their hospice stay. Prognostication
challenges and the increasing availability of cancer therapies for people with cancer set
the stage for a mismatch between certification of a 6 month prognosis and contemporary
medical care. Additionally patients often are not aware of hospice and the services they can
provide.
of patients are diagnosed with Stage III-IV disease. Nearly 80% of these patients will recur
resulting in 5-year survival rates of 14-32%. Although enrollment is increasing in hospice,
hospice programs have been challenged to reach eligible patients. Several factors limit the
number of people who enroll in hospice and the length of their hospice stay. Prognostication
challenges and the increasing availability of cancer therapies for people with cancer set
the stage for a mismatch between certification of a 6 month prognosis and contemporary
medical care. Additionally patients often are not aware of hospice and the services they can
provide.
In this study, we will pilot-test a technology-based approach for women with Stage III/IV or
recurrent ovarian cancer, their caregiver, and their providers to assist in and study the
decision-making process that surrounds end-of-life decisions, specifically, opting for
palliative care and/or entry into hospice care. We will randomize the women and their
caregivers into either our intervention or control websites. All subjects will complete a
battery of demographic, psychosocial, health status and outcomes, health information, and
decision making measures at baseline and 60-day post-baseline.
Once the participant has completed the baseline survey, he/she will be automatically brought
to their assigned website. Both the patient and their caregiver will be assigned the same
group (intervention or control). All participants will have open access to their respective
study websites for a minimum of 60 days. During enrollment, participants will agree to
access their respective websites at least 2-3 times per week. Both patients and caregivers
assigned to the control arm will view a website containing documents generally provided as
part of the usual care. They will be requested to log in with the same frequency as the
intervention group.
recurrent ovarian cancer, their caregiver, and their providers to assist in and study the
decision-making process that surrounds end-of-life decisions, specifically, opting for
palliative care and/or entry into hospice care. We will randomize the women and their
caregivers into either our intervention or control websites. All subjects will complete a
battery of demographic, psychosocial, health status and outcomes, health information, and
decision making measures at baseline and 60-day post-baseline.
Once the participant has completed the baseline survey, he/she will be automatically brought
to their assigned website. Both the patient and their caregiver will be assigned the same
group (intervention or control). All participants will have open access to their respective
study websites for a minimum of 60 days. During enrollment, participants will agree to
access their respective websites at least 2-3 times per week. Both patients and caregivers
assigned to the control arm will view a website containing documents generally provided as
part of the usual care. They will be requested to log in with the same frequency as the
intervention group.
Inclusion Criteria:
- Women with Stage III, IV or recurrent ovarian, primary peritoneal or fallopian tube
cancer or a nominated caregiver or such women
- 18 years old or older
- At least a 5th grade education
- Able to read and write in English
- Access to computer and internet
- Voluntary written informed consent before study entry, with the understanding that
consent may be withdrawn by the subject at any time without prejudice to future
medical care
- No known major psychiatric or neurological diagnosis (schizophrenia or active
chemical dependency)
Exclusion Criteria:
- Borderline ovarian cancer
We found this trial at
1
site
425 E River Pkwy # 754
Minneapolis, Minnesota 55455
Minneapolis, Minnesota 55455
612-624-2620
Masonic Cancer Center at University of Minnesota The Masonic Cancer Center was founded in 1991....
Click here to add this to my saved trials
